News

29 July 2022

EDCTP Annual Report 2021: achieving excellence and equity in global health research

Nine years since its launch, the second EDCTP programme (EDCTP2) is already achieving its objectives and successfully advancing the development of medical interventions and building…

26 July 2022

EDCTP National Health Research Systems 2020 survey report

Recent public health emergencies in Africa have shown that countries with poor health research systems and weak research infrastructure need to be strengthened to meet…

16 June 2022

EDCTP welcomes members of the new Association Board

On 23 May 2022 the EDCTP Association General Assembly appointed the members of the new EDCTP Association Board. EDCTP’s Association Board members fulfill an essential…

29 April 2022

Belgium and Côte d'Ivoire join EDCTP Association

EDCTP is pleased to welcome Belgium and Côte d’Ivoire on board as the newest member countries of the EDCTP Association. Belgium will be represented in…

25 April 2022

World Malaria Day 2022: EDCTP supports innovative approaches to fight malaria

On this year’s World Malaria Day, EDCTP joins its partners and stakeholders in harnessing innovation to reduce the malaria disease burden and save lives. EDCTP…

07 April 2022

Fifteen “EPI-Biostat Fellows” start their Master’s training at the Jomo Kenyatta University of Agriculture and Technology in Kenya

The European & Developing Countries Clinical Trials Partnership (EDCTP) and the Africa Centres for Disease Control and Prevention (Africa CDC) are partnering to train 150…

07 April 2022

Fifteen “EPI-Biostat Fellows” start their Master’s training at the Kinshasa School of Public Health in the Democratic Republic of Congo

The Kinshasa School of Public Health (KSPH) has enrolled 15 students into its Master’s training programme “MSc EpiBiostat” coordinated by Prof. Dr Mashinda Kulimba Désiré.…

24 March 2022

Single dose of liposomal amphotericin B as effective in treating HIV-associated cryptococcal meningitis as current standard of care

An EDCTP-funded phase III trial of the AMBITION-cm research team confirms that an alternative formulation of amphotericin B, delivered in tiny lipid-based packages (liposomes), would…

24 March 2022

World TB Day 2022: EDCTP invests to End TB

On this year’s World TB Day, EDCTP joins the global health community in a call to urgently raise investments to achieve the commitments to end…

08 March 2022

International Women’s Day 2022: EDCTP efforts to break the bias in health research

On this year’s International Women’s Day, EDCTP joins the global health community in celebrating women’s achievements, raising awareness against bias, and taking action for equality.…

25 February 2022

5FC HIV-Crypto consortium starts trial on improved treatment of cryptococcal meningitis in advanced HIV disease

A consortium of leading scientists and institutions in Africa and Europe, the 5FC HIV-Crypto consortium, has launched a project that aims to deliver an improved…

17 February 2022

EDCTP joins Europe PubMed Central

EDCTP has become a member of Europe PMC (PubMed Central), an open science platform that maintains a worldwide collection of scientific articles and research outputs.…

30 January 2022

World NTD Day 2022 – EDCTP remains 100% committed to ending neglected tropical diseases

In another year of changes in the funding landscape, EDCTP has stayed 100% committed to ending neglected infectious diseases. Global investment into research and development…

20 January 2022

Call for expression of interest for Global Health EDCTP3 Joint Undertaking scientific committee

The Global Health EDCTP3 Joint Undertaking (GH EDCTP3 JU) has now opened a call for expression of interest for the selection of the members of…

18 January 2022

EDCTP mourns the loss of Dr Ricardo Pereira

On 11 January 2022, our dear colleague Dr Ricardo Pereira, Science Officer at the Portuguese Foundation for Science and Technology (FCT) and EDCTP General Assembly…